Meny

Javascript verkar inte påslaget? - Vissa delar av Lunds universitets webbplats fungerar inte optimalt utan javascript, kontrollera din webbläsares inställningar.
Du är här

Dosimetry in patients with B-cell lymphoma treated with [90Y]ibritumomab tiuxetan or [131I]tositumomab.

Författare:
  • Katarina Sjögreen Gleisner
  • Y K Dewaraja
  • C Chiesa
  • Jan Tennvall
  • Ola Lindén
  • Sven-Erik Strand
  • Michael Ljungberg
Publiceringsår: 2011
Språk: Engelska
Sidor: 126-154
Publikation/Tidskrift/Serie: Quarterly Journal of Nuclear Medicine and Molecular Imaging
Volym: 55
Nummer: 2
Dokumenttyp: Artikel i tidskrift
Förlag: Edizioni Minerva Medica

Abstract english

Radioimmunotherapy involves the use of radiolabeled monoclonal antibodies (MAbs) to treat malignancy. The therapeutic effect is determined by the radiopharmaceutical, the radiation absorbed dose and previous treatments. There are currently two approved radiopharmaceuticals for the treatment of B-cell lymphoma - the 90Y-labeled ibritumomab and the 131I-labeled tositumomab. Both are directed against CD20, albeit not against the same epitope. This paper summarizes current results of dose-responses for normal tissues and tumours of [131I]tositumomab and [90Y]ibritumomab tiuxetan, discusses them in the context of dosimetry methods used and highlights the assumptions being made in the different dosimetry methodologies. Moreover, we wish to point at the possibility of performing low-cost therapy bremsstrahlung imaging for [90Y]ibritumomab tiuxetan to confirm biodistribution, and possibly also for dosimetric calculations.

Keywords

  • Radiology, Nuclear Medicine and Medical Imaging
  • Cancer and Oncology
  • Lymphoma
  • Dosimetry
  • Antibodies
  • monoclonal
  • Radioimmunotherapy

Other

Published
  • ISSN: 1824-4785
Michael Ljungberg
E-post: michael [dot] ljungberg [at] med [dot] lu [dot] se

Professor

Medicinsk strålningsfysik, Lund

+46 46 17 35 65

+46 70 817 31 15

SUS Lund Kampradhuset 12-11

Barngatan 2:1, Lund

32

Avdelningschef

Medicinsk strålningsfysik, Lund

32

Avdelningsföreståndare

Medicinsk strålningsfysik, Lund

32

Projektledare

Nuclear Medicine Physics

32